Italy's Angelini Family Expands Pharma Business into U.S. Market

Italy's Angelini family, with a $2.5 billion pharmaceutical operation built over four generations, has made a strategic move to enter the U.S. market, expanding its reach beyond Europe where it specializes in drugs for depression and epilepsy.

20 Aug, 10:30 — 20 Aug, 10:30

Post Share

Sources

Showing 1 of 1 sources

forbes6d ago

Italy’s $10 Billion Pharma Family Makes A U.S. Power Move

For four generations, Rome’s Angelini family has built a $2.5 billion operation with drugs for depression and epilepsy in Europe. Now it’s bought its way into the U.S. market.

By Amy Feldman, Forbes Staff

Read full article →

PERSPECTA

PERSPECTA

Italy's Angelini Family Expands Pharma Business into U.S. Market

Sources

Italy’s $10 Billion Pharma Family Makes A U.S. Power Move

Related Stories

Nvidia Posts Record Second-Quarter Revenue Amid Surging AI Chip Demand

Riverview Bancorp and Dycom Authorize New Stock Repurchase Programs

Trump Signs Order Restricting Foreign Equipment in U.S. Energy Grid

Enbridge Acquires Salt Creek Midstream Assets in $600 Million Deal

PERSPECTA